Skip to content

This site is intended for healthcare professionals in the UK only. Prescribing information and Adverse Event (AE) reporting details can be found in the footer.

  • Why Zegluxen®
    • Therapeutic indications
    • Clinical efficacy
    • Mechanism of action
    • Patient eligibility
  • Cost savings
  • How to Administer
    • Dose Titration
    • Storage and shelf life
    • Method of administration
  • Safety & Tolerability
    • Possible side effects
    • Special warnings and precautions for use
    • Special populations
    • Drug interactions
  • Supporting information
    • FAQs
  • Why Zegluxen®
    • Therapeutic indications
    • Clinical efficacy
    • Mechanism of action
    • Patient eligibility
  • Cost savings
  • How to Administer
    • Dose Titration
    • Storage and shelf life
    • Method of administration
  • Safety & Tolerability
    • Possible side effects
    • Special warnings and precautions for use
    • Special populations
    • Drug interactions
  • Supporting information
    • FAQs

Method of administration

For instructions on how to use the Zegluxen® pre-filled pen, your patients can watch the video or use the step-by-step guide below

Two Zegluxen packs side-by-side

For instructions on how to use the Zegluxen® pre-filled pen, your patients can watch the video or use the step-by-step guide below

How to use the Zegluxen® pen

https://liraglutide.co.uk/zegluxen-patient/wp-content/uploads/sites/7/2026/01/Zegluxen-How-to-Video-V2-000762547-Oct-25.mp4

Step-by-step guide on how to use the pre-filled pen

Label of Zegluxen pre-filled pen

Patients should check the name and coloured label of the pen to ensure that it contains Zegluxen. Using the wrong medicine could cause them severe harm. Once checked, they can pull off the pen cap”

Pen cap pulling apart, solution is clear inside

Patients should check that the solution in the pen is clear and colourless by looking through the pen window. Patients should not use the pen if the solution looks cloudy.

Removing the paper tab from the needle.

Patients should then remove the paper tab from a new disposable needle.

Screwing the needle on to the pen.

Patients should attach the needle correctly by pushing the needle straight onto the pen and turning until it is tight.

Removing the outer pen cap.

Advise patients to remove the outer needle cap and retain it (on a clean surface) for later.

Removing the inner pen cap.

Advise patients to carefully remove the inner needle cap and dispose of it.

Turning the dose selector until the flow check symbols line up with the pointer.

Advise patients to check the flow with each new needle before injecting.
A new needle should be used with every injection to help prevent infections and blocked needles.

Tapping the upright cartridge to release air bubbles.

Advise patients to hold the pen with the needle pointing up. They should then tap the cartridge gently with their finger a few times. This will make any air bubbles collect at the top of the cartridge.

Keeping the needle pointing upright and press the dose button until the 0mg lines up with the pointer.

Patient should press and hold in the dose button until the dose counter returns to 0. The 0 must line up with the dose pointer.

A drop of solution should appear at the needle tip. If no drop appears, this step can be repeated up to 4 times.

If there is still no drop, the needle should be changed and the step repeated with the new needle.

If a drop still does not appear, the pen should be disposed of and a new pen used.

If patients do not check the flow before each injection, they may not get the prescribed dose.

Turning to 1.2mg dose

Selecting their dose. Patients should always check that the pointer lines up with the 0mg. They should turn the dose selector until their required dose lines up with the pointer (0.6mg, 1.2mg, 1.8mg). If they have selected the wrong dose, change it by turning the dose selector backwards until the dose lines up with the pointer. Patients should take care not to press the dose button when turning the dose selector backwards as medicine may come out.

Dose selector stops before required dose, showing there is not enough medicine left in the pen.

If the dose selector stops before their required dose lines up with the pointer there is not enough liraglutide left for a full dose. Patients should either: Split their dose into two injections, turn the dose selector until 0.6mg or 1.2mg lines up with the pointer, inject the dose, then prepare a new pen and inject the remaining number of mg. Encourage use of a calculator to plan the doses. Alternatively, they can inject the full dose with a new pen.

Areas of injection on body: side/back of upper arm, abdomen, front of thigh

Patients should insert the needle into their skin, as shown by their healthcare professional. Press the dose button to inject until 0 mg lines up with the pointer. Avoid touching the display or pressing the dose selector as this could block the injection.

Timer showing 6 seconds.

Keep the dose button pressed down and leave the needle under the skin for at least 6 seconds to ensure full dose is received. Pull out the needle. They may see a drop of medicine at the needle tip, this is normal and does not affect their dose.

Guiding the cap on to the needle carefully

Patients should guide the needle tip into the outer needle cap without touching the needle.

The cap is back on the needle, begin to unscrew the cap

When the needle is covered, push the outer needle cap completely on. Unscrew the needle and dispose of it carefully in their sharps bin.

Replacing the pen cap.

The pen cap can then be replaced. When the pen is empty, patients should carefully dispose of it without a needle attached, in accordance with local requirements.

  1. Zegluxen® (liraglutide) Patient Information Leaflet. Available from https://www.medicines.org.uk/emc/product/100225/pil

000762557 | January 2026

Prescribing information can be found here

  • Navigation
    • Terms of Use
    • HCP Privacy
    • Cookies Policy
    • GDPR

MORE ABOUT US

linkedin

Reporting of side effects

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Zentiva Pharma UK Ltd via our online form (https://www.zentiva.co.uk/contact/mi-form), by email (UKMedInfo@zentiva.com) or by telephone (0800 090 2408).

Copyright Zentiva Group, a.s. © 2026

I confirm I am a UK Healthcare Professional (HCP)

This page is dedicated to UK HCPs only. If you are not a UK HCP, you will be directed to the gateway page after clicking on No.

No, I am not Yes, I am